Viking $VKTX says its obesity drug VK2735 maintained up to 97% of prior weight loss with every-other-week dosing and 90% with monthly dosing.
Patients staying on weekly 17.5 mg reached ~22% weight loss by week 33 with no plateau.
Show more
